Lessons from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can We Fuel the Tumor Microenvironment in Gliomas?

Despite recent advancements in cancer immunotherapy, many patients with gliomas and glioblastomas have yet to experience substantial therapeutic benefits. Modulating the tumor microenvironment (TME) of gliomas, which is typically “cold”, is crucial for improving treatment outcomes. Clinical tumor sp...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lan Hoc Phung, Takahide Nejo, Hideho Okada
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-08-01
Edice:	Vaccines
Témata:	glioblastoma glioma neoadjuvant treatment immunotherapy clinical trials trial designs
On-line přístup:	https://www.mdpi.com/2076-393X/12/8/862
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!